Bioteque (TWO:4107) — Stock Price
Bioteque (TWO:4107) is currently trading at NT$115.50 TWD, down 0.86% today. Over the past 52 weeks, shares have ranged between NT$110.50 and NT$129.00. This page tracks Bioteque's live share price on the TWO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Bioteque (4107) total market value.
Bioteque (4107) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Bioteque's daily closing share price and trading volume on the TWO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Bioteque Income Statement — Revenue, Profit & Earnings by Year
Bioteque's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | NT$2.14 Billion | NT$2.07 Billion | NT$1.94 Billion | NT$2.01 Billion | NT$1.83 Billion |
| Cost of Revenue | NT$1.20 Billion | NT$1.17 Billion | NT$1.14 Billion | NT$1.17 Billion | NT$1.02 Billion |
| Gross Profit | NT$936.93 Million | NT$905.08 Million | NT$805.35 Million | NT$844.54 Million | NT$802.87 Million |
| Research & Development | NT$73.30 Million | NT$76.26 Million | NT$70.44 Million | NT$69.98 Million | NT$68.83 Million |
| SG&A | NT$193.36 Million | NT$185.65 Million | NT$91.22 Million | NT$89.39 Million | NT$83.66 Million |
| Total Operating Expenses | NT$1.47 Billion | NT$1.43 Billion | NT$225.17 Million | NT$266.17 Million | NT$254.94 Million |
| Operating Income | NT$670.28 Million | NT$643.17 Million | NT$580.18 Million | NT$627.50 Million | NT$540.09 Million |
| EBITDA | — | — | NT$736.14 Million | NT$759.13 Million | NT$662.30 Million |
| EBIT | — | — | NT$580.18 Million | NT$627.50 Million | NT$540.09 Million |
| Interest Expense | NT$7.54 Million | NT$9.37 Million | NT$11.60 Million | NT$4.32 Million | NT$1.90 Million |
| Income Before Tax | NT$674.62 Million | NT$678.37 Million | NT$569.51 Million | NT$623.18 Million | NT$538.20 Million |
| Income Tax Expense | — | — | NT$116.97 Million | NT$129.64 Million | NT$106.94 Million |
| Net Income | NT$539.18 Million | NT$528.26 Million | NT$452.55 Million | NT$493.54 Million | NT$431.26 Million |
Bioteque Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Bioteque's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | NT$4.66 Billion | NT$4.65 Billion | NT$4.62 Billion | NT$4.48 Billion | NT$3.86 Billion |
| Total Current Assets | NT$2.33 Billion | NT$2.22 Billion | NT$2.15 Billion | NT$1.92 Billion | NT$1.95 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | NT$506.88 Million | NT$360.09 Million | NT$210.72 Million | NT$250.26 Million | NT$439.50 Million |
| Net Receivables | NT$243.68 Million | NT$192.66 Million | NT$259.16 Million | NT$290.93 Million | NT$287.42 Million |
| Inventory | NT$294.36 Million | NT$320.70 Million | NT$294.64 Million | NT$331.71 Million | NT$314.91 Million |
| Property, Plant & Equipment | — | — | — | NT$2.33 Billion | NT$1.84 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | NT$1.05 Billion | NT$1.20 Billion | NT$1.43 Billion | NT$1.45 Billion | NT$1.06 Billion |
| Total Current Liabilities | NT$546.66 Million | NT$565.35 Million | NT$642.06 Million | NT$573.73 Million | NT$595.25 Million |
| Long-term Debt | NT$153.29 Million | NT$296.43 Million | NT$446.23 Million | NT$523.08 Million | NT$105.30 Million |
| Net Debt | — | — | NT$-459.68 Million | NT$-144.69 Million | NT$-398.78 Million |
| Total Stockholder Equity | NT$3.61 Billion | NT$3.44 Billion | NT$3.19 Billion | NT$3.03 Billion | NT$2.80 Billion |
| Retained Earnings | NT$1.97 Billion | NT$1.83 Billion | NT$1.66 Billion | NT$1.51 Billion | NT$1.39 Billion |
Bioteque Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Bioteque generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | NT$664.20 Million | NT$702.62 Million | NT$669.40 Million | NT$644.58 Million | NT$469.25 Million |
| Capital Expenditures | NT$57.50 Million | NT$98.43 Million | NT$97.59 Million | NT$726.83 Million | NT$550.87 Million |
| Free Cash Flow | NT$606.70 Million | NT$604.19 Million | NT$571.80 Million | NT$-82.25 Million | NT$-81.62 Million |
| Investing Cash Flow | — | — | — | NT$-579.83 Million | NT$-552.77 Million |
| Financing Cash Flow | — | — | NT$-301.39 Million | NT$68.77 Million | NT$-232.65 Million |
| Dividends Paid | NT$346.49 Million | NT$311.84 Million | NT$311.84 Million | NT$311.84 Million | NT$277.19 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | NT$171.55 Million | NT$162.86 Million | NT$155.96 Million | NT$131.63 Million | NT$122.20 Million |
| Change in Cash | NT$-76.31 Million | NT$-116.86 Million | NT$336.52 Million | NT$144.69 Million | NT$-320.96 Million |
Bioteque Earnings History — EPS Actual vs. Analyst Estimates
Track Bioteque's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 04, 2026 | — | — | — |
| Nov 10, 2025 | 1.97 | 1.98 | -0.51% |
| Aug 13, 2025 | 1.62 | 1.88 | -13.83% |
| May 08, 2025 | — | — | — |
| Mar 04, 2025 | — | — | — |
| Nov 07, 2024 | — | — | — |
| Mar 12, 2024 | 1.51 | 2.05 | -26.34% |
| Nov 09, 2023 | 2.10 | 1.94 | +8.25% |